Exchange: NASDAQ·Updated 07:30 PM EDT
CNSP logo

CNSP Cns Pharmaceuticals Inc

$5.51
$0.0774
(1.42%)
Today
Closed $5.52
$0.0074
(0.13%)
After Hours
Mkt Cap$7.95M
Vol7,175.00

About CNSP

CNS Pharmaceuticals, Inc. is a preclinical stage pharmaceutical company, which engages in the development of anticancer drug candidates for the treatment of primary and metastatic brain and central nervous system tumors. Its product pipeline includes berubicin, and CNS-12. The company was founded by Waldemar Priebe in July 2017 and is headquartered in Houston, TX.
66

Bullish Sentiment

How do you feel about CNSP?

Advertisement|Remove ads.